RHONE-POULENC RORER's $2.6 BIL. BID FOR FISONS IS GRAB FOR BROADER ASTHMA LINE; BRITISH COMPANY REJECTS BID, STANDING BY INDEPENDENT MARKETING STRATEGY
Executive Summary
Rhone-Poulenc Rorer is offering $2.6 bil. for Fisons in an effort to expand its asthma/respiratory products presence worldwide.